Lynn Dorsey Bleil
CIK 1607309 · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FOLD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PRINCETON, NJ 08542
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 0 | $14.49 | $0 | $250.0K | 10 | 2026-04-27 |
| STERICYCLE INC (SRCL) Delisted | Director | 0 | $61.98 | $0 | $0 | 18 | 2024-11-04 |
| STERICYCLE INC (SRCLP) Delisted | Director | 495 | — | — | $0 | 6 | 2018-05-25 |
| DST SYSTEMS INC (DST) Delisted | Director | 15,987 | — | — | $149.2K | 10 | 2017-12-12 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Director | — | — | — | $0 | 1 | 2015-05-06 |
Recent Filings · Page 3 of 5
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-01 | STERICYCLE INC (SRCL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-01 | STERICYCLE INC (SRCL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-01 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +6,250 | $0 | EDGAR |
| 2019-05-24 | STERICYCLE INC (SRCL) Delisted | Exer (M) | +1,970 | $0 | EDGAR |
| 2019-05-23 | STERICYCLE INC (SRCL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-09-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +9,600 | $0 | EDGAR |
| 2018-05-25 | STERICYCLE INC (SRCLP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-02 | STERICYCLE INC (SRCLP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-18 | — | Disp (D) | −15,987 | -$1.34M | |
| 2018-02-01 | STERICYCLE INC (SRCLP) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.